retatrutide nonalcoholic steatohepatitis trial nash Pharmacotherapy for NASH: Current and emerging Drugs for Non-alcoholic Steatohepatitis (NASH): – Xia & He Publishing

The most well-known GLP-1s have demonstrated a powerful ability to protect the heart and blood vessels

Wegovy comes in 5 different dosages

Nutrients and supplements that matter for both conditions Hashimoto's patients on GLP-1 medications face a double challenge: the autoimmune condition depletes certain nutrients, and the GLP-1 medication's appetite suppression and altered gastric emptying can reduce nutrient intake and absorption further

We have not observed any difference in the rate of acute pancreatitis or gastrointestinal disturbance associated with GLP-1 RA compared to SGLT2i therapy and patients with type 1 diabetes